INBX
Inhibrx Biosciences (INBX) Investor Questions
Review Inhibrx Biosciences (INBX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Inhibrx Biosciences
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 55
- Annual revenue
- $1.30M
- Annual net income
- $-140.06M
- Annual free cash flow
- $-129.82M
Inhibrx Biosciences (INBX) Investor Questions research
Inhibrx Biosciences trades under the ticker INBX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review INBX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.